Literature DB >> 33236959

Iron Accumulation, Not β-Amyloid or Brain Volumes, Is Linked to Cognition in Older Patients Who Are Nondemented.

Gloria C Chiang1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33236959      PMCID: PMC7853849          DOI: 10.1148/radiol.2020204157

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  10 in total

1.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

Authors:  M A Smith; P L Harris; L M Sayre; G Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals.

Authors:  L M Sayre; G Perry; P L Harris; Y Liu; K A Schubert; M A Smith
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

3.  Intramuscular desferrioxamine in patients with Alzheimer's disease.

Authors:  D R Crapper McLachlan; A J Dalton; T P Kruck; M Y Bell; W L Smith; W Kalow; D F Andrews
Journal:  Lancet       Date:  1991-06-01       Impact factor: 79.321

4.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

Authors:  Willemijn J Jansen; Rik Ossenkoppele; Dirk L Knol; Betty M Tijms; Philip Scheltens; Frans R J Verhey; Pieter Jelle Visser; Pauline Aalten; Dag Aarsland; Daniel Alcolea; Myriam Alexander; Ina S Almdahl; Steven E Arnold; Inês Baldeiras; Henryk Barthel; Bart N M van Berckel; Kristen Bibeau; Kaj Blennow; David J Brooks; Mark A van Buchem; Vincent Camus; Enrica Cavedo; Kewei Chen; Gael Chetelat; Ann D Cohen; Alexander Drzezga; Sebastiaan Engelborghs; Anne M Fagan; Tormod Fladby; Adam S Fleisher; Wiesje M van der Flier; Lisa Ford; Stefan Förster; Juan Fortea; Nadia Foskett; Kristian S Frederiksen; Yvonne Freund-Levi; Giovanni B Frisoni; Lutz Froelich; Tomasz Gabryelewicz; Kiran Dip Gill; Olymbia Gkatzima; Estrella Gómez-Tortosa; Mark Forrest Gordon; Timo Grimmer; Harald Hampel; Lucrezia Hausner; Sabine Hellwig; Sanna-Kaisa Herukka; Helmut Hildebrandt; Lianna Ishihara; Adrian Ivanoiu; William J Jagust; Peter Johannsen; Ramesh Kandimalla; Elisabeth Kapaki; Aleksandra Klimkowicz-Mrowiec; William E Klunk; Sebastian Köhler; Norman Koglin; Johannes Kornhuber; Milica G Kramberger; Koen Van Laere; Susan M Landau; Dong Young Lee; Mony de Leon; Viviana Lisetti; Alberto Lleó; Karine Madsen; Wolfgang Maier; Jan Marcusson; Niklas Mattsson; Alexandre de Mendonça; Olga Meulenbroek; Philipp T Meyer; Mark A Mintun; Vincent Mok; José Luis Molinuevo; Hanne M Møllergård; John C Morris; Barbara Mroczko; Stefan Van der Mussele; Duk L Na; Andrew Newberg; Agneta Nordberg; Arto Nordlund; Gerald P Novak; George P Paraskevas; Lucilla Parnetti; Gayan Perera; Oliver Peters; Julius Popp; Sudesh Prabhakar; Gil D Rabinovici; Inez H G B Ramakers; Lorena Rami; Catarina Resende de Oliveira; Juha O Rinne; Karen M Rodrigue; Eloy Rodríguez-Rodríguez; Catherine M Roe; Uros Rot; Christopher C Rowe; Eckart Rüther; Osama Sabri; Páscual Sanchez-Juan; Isabel Santana; Marie Sarazin; Johannes Schröder; Christin Schütte; Sang W Seo; Femke Soetewey; Hilkka Soininen; Luiza Spiru; Hanne Struyfs; Charlotte E Teunissen; Magda Tsolaki; Rik Vandenberghe; Marcel M Verbeek; Victor L Villemagne; Stephanie J B Vos; Linda J C van Waalwijk van Doorn; Gunhild Waldemar; Anders Wallin; Åsa K Wallin; Jens Wiltfang; David A Wolk; Marzena Zboch; Henrik Zetterberg
Journal:  JAMA       Date:  2015-05-19       Impact factor: 56.272

5.  Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline.

Authors:  Scott Ayton; Amir Fazlollahi; Pierrick Bourgeat; Parnesh Raniga; Amanda Ng; Yen Ying Lim; Ibrahima Diouf; Shawna Farquharson; Jurgen Fripp; David Ames; James Doecke; Patricia Desmond; Roger Ordidge; Colin L Masters; Christopher C Rowe; Paul Maruff; Victor L Villemagne; Olivier Salvado; Ashley I Bush
Journal:  Brain       Date:  2017-08-01       Impact factor: 13.501

Review 6.  Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis.

Authors:  Yunlong Tao; Yu Wang; Jack T Rogers; Fudi Wang
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain.

Authors:  Chuang Guo; Pu Wang; Man-Li Zhong; Tao Wang; Xue-Shi Huang; Jia-Yi Li; Zhan-You Wang
Journal:  Neurochem Int       Date:  2012-12-20       Impact factor: 3.921

8.  Quantitative Susceptibility Mapping of Brain Iron and β-Amyloid in MRI and PET Relating to Cognitive Performance in Cognitively Normal Older Adults.

Authors:  Lin Chen; Anja Soldan; Kenichi Oishi; Andreia Faria; Yuxin Zhu; Marilyn Albert; Peter C M van Zijl; Xu Li
Journal:  Radiology       Date:  2020-11-24       Impact factor: 11.105

9.  Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease.

Authors:  Hyug-Gi Kim; Soonchan Park; Hak Young Rhee; Kyung Mi Lee; Chang-Woo Ryu; Sun Jung Rhee; Soo Yeol Lee; Yi Wang; Geon-Ho Jahng
Journal:  Neuroimage Clin       Date:  2017-08-24       Impact factor: 4.881

Review 10.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.